Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia.
Quantitative magnetic resonance imaging (MRI) can measure total gray matter volume but cannot discriminate between neurons and glia. Proton magnetic resonance spectroscopic imaging (1H MRSI) measures N-acetylaspartate (NAA) which is a selective marker of neuronal loss or neuronal dysfunction. The objective of this study was to obtain quantitative measures of hippocampal volume and hippocampal NAA to determine if there was evidence for hippocampal neuronal dysfunction or neuronal loss in schizophrenia. Quantitative MRI and 1H MRSI was performed on the right and left hippocampal regions in 23 chronic schizophrenic patients and 18 control subjects. Relative to the control group, the patients with schizophrenia demonstrated no change in hippocampal volumes bilaterally, but significantly decreased NAA in the hippocampal regions bilaterally. There was also no correlation between hippocampal volumes and NAA in either the schizophrenics or controls. These findings suggest that: (1) hippocampal NAA may be a more sensitive measure of neuronal loss than volumetric measurements; and (2) reduced hippocampal NAA may be measuring neuronal dysfunction or damage rather than neuronal loss in this sample of schizophrenics.
Magnetic Resonance Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA. deicken@itsa.ucsf.edu
R F
RF
Deicken
M
M
Pegues
D
D
Amend
D000328:Adult; D001224:Aspartic Acid / Q000378:metabolism*; D016923:Cell Death / Q000502:physiology; D002908:Chronic Disease; D005260:Female; D006624:Hippocampus / Q000033:anatomy & histology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009457:Neuroglia / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D012559:Schizophrenia / Q000378:metabolism* / Q000473:pathology*
D001224:Aspartic Acid